Paper
8 May 1997 Light-emitting diode versus laser irradiation phototherapy with lutetium texaphyrin (PCI-0123)
Kathryn W. Woodburn, Stuart W. Young M.D., Fan Qing, Dale R. Miles, Patricia A. Thiemann
Author Affiliations +
Abstract
Lutetium texaphyrin (PCI-0123) is presently in clinical trials for the treatment of neoplasms. An argon-pumped dye laser has mostly been used to generate light for PCI-0123 photoactivation. However, lasers are expensive and produce a limited area of illumination, so the efficacy of light emitting diodes (LEDs) was investigated. An LED array was developed so that the spectral emission matched the far red absorption spectrum of PCI-0123. A preclinical PDT efficacy study comparing the laser and the LED was undertaken using EMT6-bearing animals. The LED and laser light sources were statistically comparable in eradicating the murine mammary sarcomas using PCI-0123 as the photosensitizer.
© (1997) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kathryn W. Woodburn, Stuart W. Young M.D., Fan Qing, Dale R. Miles, and Patricia A. Thiemann "Light-emitting diode versus laser irradiation phototherapy with lutetium texaphyrin (PCI-0123)", Proc. SPIE 2972, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VI, (8 May 1997); https://doi.org/10.1117/12.273486
Lens.org Logo
CITATIONS
Cited by 6 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Light emitting diodes

Tumors

Photodynamic therapy

Light sources

Lutetium

Laser therapeutics

Dye lasers

RELATED CONTENT

Noncoherent light for PDT of spontaneous animal tumors
Proceedings of SPIE (July 13 2004)
Photodynamic therapy for port wine stains
Proceedings of SPIE (August 07 1998)
Photodynamic therapy in China
Proceedings of SPIE (March 05 1993)

Back to Top